Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
-12.11%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$36.8B
AUM Growth
-$7.5B
(-17%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
13%
Holding
2,370
New
199
Increased
691
Reduced
1,094
Closed
240
Top Buys
| 1 |
PNC Financial Services
PNC
|
+$306M |
| 2 |
Cisco
CSCO
|
+$222M |
| 3 |
Verizon
VZ
|
+$179M |
| 4 |
Amcor
AMCR
|
+$132M |
| 5 |
Truist Financial
TFC
|
+$131M |
Top Sells
| 1 |
Chevron
CVX
|
+$290M |
| 2 |
AbbVie
ABBV
|
+$197M |
| 3 |
Exxon Mobil
XOM
|
+$188M |
| 4 |
Public Service Enterprise Group
PEG
|
+$149M |
| 5 |
General Mills
GIS
|
+$122M |
Sector Composition
| 1 | Healthcare | 22.75% |
| 2 | Technology | 14.79% |
| 3 | Financials | 13.93% |
| 4 | Consumer Discretionary | 7.59% |
| 5 | Communication Services | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Evertec
EVTC
$2.14B
| $23K | ﹤0.01% |
627
-32,837
| -98% | -$1.2M |
|
1752
Pacira BioSciences
PCRX
$1.2B
| $23K | ﹤0.01% |
399
-80,543
| -100% | -$4.64M |
|
1753
RE/MAX Holdings
RMAX
$187M
| $23K | ﹤0.01% |
954
-1,206
| -56% | -$29.1K |
|
1754
Hawkins
HWKN
$3.56B
| $22K | ﹤0.01% |
615
-498
| -45% | -$17.8K |
|
1755
Karyopharm Therapeutics
KPTI
$53.8M
| $22K | ﹤0.01% |
+329
| New | +$22K |
|
1756
Lemonade
LMND
$3.63B
| $22K | ﹤0.01% |
+1,217
| New | +$22K |
|
1757
Insight Enterprises
NSIT
$3.96B
| $22K | ﹤0.01% |
261
-813
| -76% | -$68.5K |
|
|
CDMO
1758
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $22K | ﹤0.01% |
1,461
-1,186
| -45% | -$17.9K |
|
1759
Cardlytics
CDLX
$49.8M
| $21K | ﹤0.01% |
+925
| New | +$21K |
|
1760
WisdomTree
WT
$2.02B
| $21K | ﹤0.01% |
4,073
-210,128
| -98% | -$1.08M |
|
|
NXGN
1761
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $21K | ﹤0.01% |
1,185
-43,381
| -97% | -$769K |
|
1762
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $20K | ﹤0.01% |
2,725
-2,214
| -45% | -$16.3K |
|
|
MODV
1763
DELISTED
ModivCare
MODV
| $20K | ﹤0.01% |
232
-190
| -45% | -$16.4K |
|
1764
Pacific Biosciences
PACB
$366M
| $20K | ﹤0.01% |
+4,609
| New | +$20K |
|
1765
Playtika
PLTK
$1.39B
| $20K | ﹤0.01% |
+1,508
| New | +$20K |
|
1766
TTEC Holdings
TTEC
$179M
| $20K | ﹤0.01% |
289
-235
| -45% | -$16.3K |
|
1767
Travere Therapeutics
TVTX
$2.43B
| $20K | ﹤0.01% |
780
-86,154
| -99% | -$2.21M |
|
|
RTL
1768
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $20K | ﹤0.01% |
2,717
-2,205
| -45% | -$16.2K |
|
1769
iShares MSCI South Korea ETF
EWY
$5.38B
| $19K | ﹤0.01% |
325
| – | – |
|
1770
Fulgent Genetics
FLGT
$667M
| $19K | ﹤0.01% |
353
-285
| -45% | -$15.3K |
|
1771
First Merchants
FRME
$2.32B
| $19K | ﹤0.01% |
528
-155
| -23% | -$5.58K |
|
1772
iRadimed
IRMD
$910M
| $19K | ﹤0.01% |
559
-46
| -8% | -$1.56K |
|
1773
Organon & Co
OGN
$2.67B
| $19K | ﹤0.01% |
549
-12,181
| -96% | -$422K |
|
1774
Olema Pharmaceuticals
OLMA
$536M
| $19K | ﹤0.01% |
4,565
+2,105
| +86% | +$8.76K |
|
1775
UiPath
PATH
$6.21B
| $19K | ﹤0.01% |
+979
| New | +$19K |
|